全文获取类型
收费全文 | 7201篇 |
免费 | 460篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 123篇 |
妇产科学 | 150篇 |
基础医学 | 1112篇 |
口腔科学 | 238篇 |
临床医学 | 551篇 |
内科学 | 1764篇 |
皮肤病学 | 250篇 |
神经病学 | 623篇 |
特种医学 | 201篇 |
外科学 | 863篇 |
综合类 | 57篇 |
一般理论 | 1篇 |
预防医学 | 482篇 |
眼科学 | 98篇 |
药学 | 560篇 |
中国医学 | 52篇 |
肿瘤学 | 492篇 |
出版年
2023年 | 51篇 |
2022年 | 129篇 |
2021年 | 317篇 |
2020年 | 144篇 |
2019年 | 189篇 |
2018年 | 241篇 |
2017年 | 177篇 |
2016年 | 174篇 |
2015年 | 201篇 |
2014年 | 296篇 |
2013年 | 356篇 |
2012年 | 572篇 |
2011年 | 555篇 |
2010年 | 303篇 |
2009年 | 286篇 |
2008年 | 488篇 |
2007年 | 464篇 |
2006年 | 430篇 |
2005年 | 404篇 |
2004年 | 397篇 |
2003年 | 314篇 |
2002年 | 341篇 |
2001年 | 75篇 |
2000年 | 57篇 |
1999年 | 54篇 |
1998年 | 43篇 |
1997年 | 46篇 |
1996年 | 49篇 |
1995年 | 36篇 |
1994年 | 28篇 |
1993年 | 34篇 |
1992年 | 42篇 |
1991年 | 40篇 |
1990年 | 32篇 |
1989年 | 25篇 |
1988年 | 29篇 |
1987年 | 16篇 |
1986年 | 13篇 |
1985年 | 20篇 |
1984年 | 31篇 |
1983年 | 27篇 |
1982年 | 16篇 |
1981年 | 22篇 |
1979年 | 15篇 |
1978年 | 15篇 |
1977年 | 16篇 |
1974年 | 9篇 |
1973年 | 14篇 |
1972年 | 9篇 |
1966年 | 8篇 |
排序方式: 共有7713条查询结果,搜索用时 15 毫秒
1.
2.
3.
José M. Martín M.D. Ph.D. Gerardo Beteta M.D. Andrea Allende M.D. Esperanza Jordá M.D. Ph.D. 《Pediatric dermatology》2015,32(6):e303-e304
We report on a 3‐year‐old girl with a microvesicular generalized rash in whom primary infection by parvovirus B19 was demonstrated by seroconversion. To our knowledge, this is the first instance of an eruption arising from parvovirus B19 with this peculiar clinical pattern. 相似文献
4.
5.
Clinical decisions are often made with incomplete information, yet patient care decisions are made every day. Patients vary clinically, uncertainty exists in diagnostic and prognostic information, and many preventive and treatment alternatives have not been formally assessed for their effectiveness. Because scientific information will never answer all clinical questions, clinical decisions are partially based on probabilistic information.
This paper describes how to apply clinical decision making to diagnosing and managing dental caries and periodontal diseases. By using explicit information to quantify probabilities and outcomes, clinical decision making analyzes decisions made under uncertain conditions and the uncertain impact of clinical information.
Clinical decision making incorporates concepts for preventing, diagnosing and treating dental caries and periodontal diseases: risk assessment, evidence-based dentistry, and multiple oral health outcomes. This information can serve as a tool for clinicians to augment clinical judgment and expertise. 相似文献
This paper describes how to apply clinical decision making to diagnosing and managing dental caries and periodontal diseases. By using explicit information to quantify probabilities and outcomes, clinical decision making analyzes decisions made under uncertain conditions and the uncertain impact of clinical information.
Clinical decision making incorporates concepts for preventing, diagnosing and treating dental caries and periodontal diseases: risk assessment, evidence-based dentistry, and multiple oral health outcomes. This information can serve as a tool for clinicians to augment clinical judgment and expertise. 相似文献
6.
7.
8.
Alfonso Ruiz-Bravo Khalil Kouwatli Gerardo Alvarez de Cienfuegos Alberto Ramos-Cormenzana 《Immunology letters》1981,3(1):39-43
Mice pretreated with Bacillus megaterium ATCC 33085 grown on TSA medium developed a significant increase in primary antibody response to SRBC. Conversely, pretreatment with a spore suspension harvested from nutrient Agar medium decreased this antibody response. A suspension of organisms grown on a defined, phosphorus-deficient medium (P-Medium) had no effect. Otherwise, only the spore suspension was able to enhance the contact sensitivity to dinitrofluorobenzene. Peritoneal leucocyte numbers were increased by inoculation with both TSA-cultured bacteria and the spore suspension, but not by P-Medium-cultured bacteria. Administration of both the spore suspension and P-Medium-cultured bacteria decreased the in vitro phagocytosis by peritoneal adherent cells. These immunomodulator properties are discussed in relation to characteristics of the strain tested. 相似文献
9.
Gary D. Pipes Phillip Campbell Pavel V. Bondarenko Bruce A. Kerwin Michael J. Treuheit Himanshu S. Gadgil 《Journal of pharmaceutical sciences》2010,99(11):4469-4476
A middle-down LC/MS approach, for the rapid quantitation and characterization of site-specific methionine oxidation in a recombinant monoclonal IgG1 molecule, is described. An IgG1 antibody was digested with endoprotease LysC under limited proteolytic conditions to produce two major components; an antigen binding fragment (Fab) and a crystallizable fraction (Fc). These fractions were then reduced to produce three major species; light chain (LC), Fc/2 which is the C terminal region of the heavy chain (HC) and the N-terminal heavy chain region (Fd). These three fragments were separated by reversed-phase HPLC using a diphenyl column. The diphenyl column resolved site-specific methionine oxidation in all three subunits. Middle- down N-terminal sequencing with a LCT premier mass spectrometer was used to identify the sites of oxidation in the LC. Sites of oxidation in the Fc/2 were identified using middle-down collision-induced dissociation (CID) on a Qtof premier. This method allowed for the rapid quantitation and identification of oxidation on each methionine residue in an IgG1 molecule. 相似文献
10.
A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. 总被引:3,自引:0,他引:3
Pavel Sova Xiao-Wei Ren Shaoheng Ni Kathrin M Bernt Jie Mi Nancy Kiviat André Lieber 《Molecular therapy》2004,9(4):496-509
We have constructed a new capsid-modified adenovirus (Ad) vector that specifically replicates in tumor cells and expresses TNF-related apoptosis-inducing ligand (TRAIL). The Ad capsid contains short-shafted fibers derived from Ad serotype 35, which allow for efficient infection of malignant tumor cells, and largely avoids innate toxicity after intravenous application. Replication-dependent homologous recombination in Ad genomes was used to achieve tumor-specific expression of Ad E1a (to mediate viral replication) and TRAIL (to mediate apoptosis and enhance release of progeny virus from infected cells). We demonstrated that our oncolytic vector (Ad5/35.IR-E1A/TRAIL) induced apoptosis in human tumor cell lines derived from colorectal, lung, prostate, and liver cancer. Both in vitro and in vivo tumor models showed efficient intratumoral spread of this vector. In a model for metastatic colon cancer, tail vein infusion of Ad5/35.IR-E1A/TRAIL resulted in elimination of preestablished liver metastases. Intravenous injection of this vector caused a transient elevation of serum glutamic pyruvic transaminase in tumor-bearing mice, which we attributed to factors released from apoptotic tumor cells. Liver histology analyzed at day 14 after virus injection did not show signs of hepatocellular damage. This new oncolytic vector represents a potentially efficient means for gene therapy of metastatic cancer. 相似文献